Category: Portfolio management

Are Gaps in Your Knowledge of PPM Limiting Your Company’s Performance?

Biotech and pharma companies place high hopes on product and portfolio management (PPM) but are often disappointed by the outcomes: hodgepodge portfolios with pipeline gaps and too many projects, weak pet projects that live on despite warning signs, and budgets that don’t reflect the company’s strategy. Decisions are often biased and delayed, and teams spend too much time on PPM, preventing potentially groundbreaking drugs from entering the clinic. The implications of these outcomes are costly. (Read more…)

Filed under: Portfolio management | Lynley @ 12:18 AM | | Comments (0)

  • Blog home

  • You are currently browsing the archives for the Portfolio management category.